Development Agreement - Seattle Genetics Inc. and GTC Corp.
DEVELOPMENT AGREEMENT
This Agreement is made and entered into on this 20th day of July, 1999 ("Effective Date") between Seattle Genetics, Inc. ("Seattle Genetics"), a Delaware corporation with offices at 22215 26th Avenue, Bothell, WA 98021 and GTC Corporation ("GTC"), a Massachusetts corporation with offices at 175 Crossing Boulevard, Framingham, MA 01701-9322.
Whereas, Seattle Genetics and GTC agree to collaborate under the following terms and conditions on the further development of humanized huBR96-2 mAb with the intent of determining the clinical and commercial potential for this version of BR96. In consideration of the mutual promises and covenants set forth herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:
Seattle Genetics and GTC represent to one another that they have the right to enter into this Agreement, as well as the right to further develop and commercialize tg huBR96-2 mAb as contemplated by this Agreement.
EXCEPT AS SET FORTH ABOVE, THE PARTIES EXCLUDE FROM THIS AGREEMENT ALL REPRESENTATIONS AND WARRANTIES INCLUDING, BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF MERCHANTAB1LITY AND OF FITNESS FOR A PARTICULAR PURPOSE.
Seattle Genetics and GTC anticipate that they will exchange proprietary and confidential information during the term of this Agreement. The use and disclosure of such information is governed by the agreement of the panics pertaining to confidentiality, executed by the panics on or before the date of this Agreement ("Non-Disclosure"), a copy of which is attached hereto as Exhibit A.
[*] Confidential treatment requested
1
This Agreement shall be governed by and construed in accordance with the laws of the Commonwealth of Massachusetts, excluding its principles relating to conflict of laws.
In witness whereof, the parties have caused this Agreement to be executed by their authorized representatives, to be effective as of the Effective Date above.
GENZYME TRANSGENICS CORPORATION | ||||
By: |
|
/s/ MICHAEL W. YOUNG |
|
|
Name: | Michael W. Young | |||
Title: | V.P. Commercial Development | |||
Date: | 16 July 1999 | |||
SEATTLE GENETICS, INC. |
|
|
||
By: |
|
/s/ H. PERRY FELL |
|
|
Name: | H. Perry Fell | |||
Title: | President | |||
Date: | 7-20-99 |
2